Literature DB >> 33447565

Caveolin-1 regulates the expression of miR-183 and inhibits the invasion and migration of invasive pituitary adenomas by affecting early growth response 1 (EGR1)/Krueppel-like factor 5 (KLF5) interaction.

Huan Ma1, Zheying Zhang2, Yang Wang1, Fei Shang1, Baoshun Du1, Yungang Wang1, Zhenguo Cheng1.   

Abstract

BACKGROUND: This study aims to investigate the mechanism through which Caveolin-1 (CAV-1) regulates the expression of micro ribonucleic acid (miR)-183 in invasive pituitary adenoma (IPA) tissues and GH3 cells, and explore the effects of CAV-1 and miR-183 on the invasion and migration ability of GH3 cells.
METHODS: Western blotting was used to detect the expression level of CAV-1, early growth response 1 (EGR1) and Krueppel-like factor 5 (KLF5). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect the expression of miR-183. The mechanisms of interaction between CAV-1, EGR1, and KLF5 were studied by immunoprecipitation experiments. Transwell and cell scratch tests were used to determine the invasion and migration ability of GH3 cells. The dual-luciferase reporter gene experiment was used to detect the effects of EGR1 and KLF5 on miR-183 luciferase activity and verify the targeting relationship between miR-183 and ezrin.
RESULTS: The expression of CAV-1 was up-regulated. However, following the knockdown of CAV-1, the invasion and migration ability of GH3 cells was significantly inhibited (P<0.05). The expression of miR-183 was down-regulated, but the expression level of miR-183 was markedly increased following the knockdown of CAV-1 (P<0.05). The knockdown of CAV-1 inhibited the nuclear ectopic of the EGR1 protein in GH3 cells. At the same time, the interaction between EGR1 and KLF5 in GH3 cells was significantly inhibited (P<0.05). The luciferase activity of miR-183 increased significantly after overexpression of KLF5 while overexpression of EGR1 and KLF5 had no significant effect on intracellular luciferase activity. Overexpression of miR-183 markedly inhibited the luciferase activity of wild-type EZR and the expression of the EZR protein in GH3 cells. Furthermore, the overexpression of miR-183 or the inhibition of EZR can reduce the invasion and migration ability of GH3 cells. The simultaneous overexpression or inhibition of miR-183 and EZR expression has no obvious effect on the invasion and migration ability of GH3 cells.
CONCLUSIONS: CAV-1 up-regulates the expression of miR-183 by inhibiting the nuclear ectopic of EGR1 and the interaction between EGR1 and KLF5 in GH3 cells. Also, miR-183 negatively regulates the expression of EZR and inhibits the invasion and migration of GH3 cells. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Invasive pituitary adenoma (IPA); immunoprecipitation; invasion; miR-183; migration; nuclear ectopic; transcription factor

Year:  2020        PMID: 33447565      PMCID: PMC7804526          DOI: 10.21037/gs-20-823

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  24 in total

1.  Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.

Authors:  Hengyi Fan; Raorao Yuan; Shiqi Cheng; Kun Xiong; Xingen Zhu; Yan Zhang
Journal:  Biomed Pharmacother       Date:  2017-11-22       Impact factor: 6.529

2.  A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.

Authors:  Yong Chen; Hong-Li Chuan; Sheng-Yuan Yu; Chu-Zhong Li; Zhe-Bao Wu; Gui-Lin Li; Ya-Zhuo Zhang
Journal:  World Neurosurg       Date:  2017-01-16       Impact factor: 2.104

3.  Reduction of miR-212 contributes to pituitary adenoma cell invasion via targeting c-Met.

Authors:  Hong-Yan Wang; Huai-Qing Gao
Journal:  Kaohsiung J Med Sci       Date:  2019-10-23       Impact factor: 2.744

Review 4.  Caveolin-1, cancer and therapy resistance.

Authors:  Julia Ketteler; Diana Klein
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

5.  MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.

Authors:  D-W Wang; Y-Q Wang; H-S Shu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-03       Impact factor: 3.507

6.  Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.

Authors:  Blanca Torrejón; Ion Cristóbal; Federico Rojo; Jesús García-Foncillas
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

7.  Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Beata Rak; Dawid Mehlich; Filip Garbicz; Grzegorz Zieliński; Maria Maksymowicz; Emir Sajjad; Paweł K Włodarski
Journal:  Endocrine       Date:  2019-06-04       Impact factor: 3.633

8.  Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli.

Authors:  Heedoo Lee; Chunhua Li; Yang Zhang; Duo Zhang; Leo E Otterbein; Yang Jin
Journal:  J Exp Med       Date:  2019-06-24       Impact factor: 14.307

9.  The paracrine induction of prostate cancer progression by caveolin-1.

Authors:  Chun-Jung Lin; Eun-Jin Yun; U-Ging Lo; Yu-Ling Tai; Su Deng; Elizabeth Hernandez; Andrew Dang; Yu-An Chen; Debabrata Saha; Ping Mu; Ho Lin; Tsai-Kun Li; Tang-Long Shen; Chih-Ho Lai; Jer-Tsong Hsieh
Journal:  Cell Death Dis       Date:  2019-11-04       Impact factor: 8.469

10.  The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma.

Authors:  Haibo Zhu; Yazhou Miao; Yutao Shen; Jing Guo; Weiyan Xie; Sida Zhao; Wei Dong; Yazhuo Zhang; Chuzhong Li
Journal:  J Transl Med       Date:  2019-10-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.